Seung Joon Kim Selected Research

Seung Joon Kim Research Topics

Disease

30	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 08/2013
14	Lung Neoplasms (Lung Cancer) 01/2024 - 03/2013
12	Neoplasms (Cancer) 03/2022 - 03/2013
11	Inflammation (Inflammations) 05/2021 - 04/2007
11	Asthma (Bronchial Asthma) 03/2014 - 06/2006
9	Airway Remodeling 01/2013 - 06/2006
7	Neoplasm Metastasis (Metastasis) 01/2024 - 04/2014
7	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 12/2014
5	Pneumonia (Pneumonitis) 01/2023 - 07/2012
5	Respiratory Hypersensitivity 03/2014 - 04/2007
4	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 12/2022 - 04/2011
4	Adenocarcinoma of Lung 01/2021 - 01/2017
3	Disease Progression 01/2023 - 03/2017
3	Prostatic Neoplasms (Prostate Cancer) 11/2022 - 04/2014
3	Pleural Effusion (Pleural Effusions) 01/2022 - 08/2013
3	Adenocarcinoma 10/2019 - 02/2011
3	Carcinogenesis 10/2017 - 02/2011
2	Anemia 01/2023 - 05/2020
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 08/2021 - 03/2015
2	Carcinoma (Carcinomatosis) 05/2020 - 04/2014
2	Neutropenia 05/2020 - 01/2015
2	Hypoxia (Hypoxemia) 07/2017 - 01/2017
2	Hyperplasia 11/2009 - 04/2007
1	Tuberculosis (Tuberculoses) 11/2023
1	Infections 01/2023
1	Hyperkalemia 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Pulmonary Tuberculosis 01/2022
1	Brain Neoplasms (Brain Tumor) 12/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 03/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 07/2019
1	Dyspnea (Shortness of Breath) 05/2017

Drug/Important Bio-Agent (IBA)

17	ErbB Receptors (EGF Receptor)IBA 11/2023 - 08/2013
9	Tyrosine Kinase InhibitorsIBA 01/2023 - 08/2013
8	CytokinesIBA 03/2014 - 06/2006
7	AfatinibIBA 11/2023 - 12/2020
7	Biomarkers (Surrogate Marker)IBA 09/2023 - 12/2013
7	OvalbuminIBA 03/2014 - 04/2007
5	Interleukin-13IBA 09/2013 - 04/2007
3	osimertinibIBA 10/2023 - 01/2021
3	Immune Checkpoint InhibitorsIBA 04/2023 - 05/2021
3	PlatinumIBA 12/2022 - 03/2017
3	MethyltransferasesIBA 01/2020 - 03/2013
3	hydrogen sulfite (bisulfite)IBA 01/2020 - 03/2013
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2013 - 04/2007
3	Immunoglobulin E (IgE)IBA 01/2013 - 04/2007
3	AllergensIBA 01/2011 - 01/2009
3	Methacholine Chloride (Methacholine)FDA Link 05/2010 - 04/2007
2	CrizotinibIBA 01/2024 - 01/2024
2	Anaplastic Lymphoma KinaseIBA 01/2024 - 01/2015
2	polyphenon EIBA 11/2022 - 04/2014
2	A-Form DNA (A-DNA)IBA 01/2020 - 08/2015
2	Gefitinib (Iressa)FDA Link 07/2019 - 01/2017
2	Benzo(a)pyreneIBA 10/2017 - 12/2014
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 10/2017 - 12/2014
2	Phosphodiesterase 4 InhibitorsIBA 10/2017 - 12/2014
2	MicroRNAs (MicroRNA)IBA 03/2017 - 02/2011
2	AntibodiesIBA 03/2017 - 05/2010
2	Histone Deacetylase InhibitorsIBA 08/2015 - 03/2013
2	trichostatin A (A 300)IBA 08/2015 - 03/2013
2	theasinensin AIBA 08/2015 - 03/2013
2	InterleukinsIBA 03/2014 - 09/2013
2	CamptothecinIBA 10/2013 - 04/2011
2	belotecanIBA 10/2013 - 04/2011
2	DNA (Deoxyribonucleic Acid)IBA 03/2013 - 06/2006
2	Immunoglobulin G (IgG)IBA 01/2013 - 04/2007
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2013 - 07/2012
2	CollagenIBA 07/2012 - 05/2010
2	Interleukin-4 (Interleukin 4)IBA 12/2007 - 06/2006
1	durvalumabIBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	necrostatin-1IBA 01/2023
1	bardoxolone methylIBA 01/2023
1	atezolizumabIBA 12/2022
1	Etoposide (VP 16)FDA LinkGeneric 12/2022
1	delpazolidIBA 01/2022
1	OsteopontinIBA 01/2022
1	Linezolid (Zyvox)FDA Link 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	Carbon MonoxideIBA 09/2020
1	matrigelIBA 01/2020
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020
1	Nicotine FDA Link 07/2019
1	B7-H1 AntigenIBA 07/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2017
1	CarcinogensIBA 10/2017
1	RoflumilastIBA 10/2017
1	Budesonide (Pulmicort)FDA LinkGeneric 10/2017
1	Oxygen (Dioxygen)IBA 07/2017

Therapy/Procedure

9	Therapeutics 01/2023 - 01/2011
5	Drug Therapy (Chemotherapy) 11/2021 - 10/2014
4	Immunotherapy 09/2023 - 01/2019
3	Radiotherapy 08/2021 - 05/2020
2	Adjuvant Chemotherapy 03/2017 - 01/2016
2	Chemoprevention 12/2014 - 04/2014
1	Precision Medicine 11/2023
1	Drug Tapering 12/2021
1	Organ Transplantation 05/2017